Rosing H | Netherlands Cancer Inst. Amsterdam Nld
スポンサーリンク
概要
関連著者
-
Rosing H
Netherlands Cancer Inst. Amsterdam Nld
-
Rosing H.
Department Of Pharmacy And Pharmacology Slotervaart Hospital/the Netherlands Cancer Institute
-
Beijnen J.
Utrecht University Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical An
-
Beijnen J.
Department Of Medical Oncology The Netherlands Cancer Institute/antoni Van Leeuwenhoek Huis
-
Rosing H.
Dept. Of Pharmacy And Pharmacology Slotervaart Hospital/netherlands Cancer Institute
-
Rosing H.
Department Of Pharmacy Slotervaart Hospital
-
Rosing H.
Department Of Pharmacy & Pharmacology Slotervaart Hospital/the Netherlands Cancer Institute
-
Schellens J
Utrecht University Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical An
-
Schellens J.
Utrecht University Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical An
-
Schellens J.
Department Of Medical Oncology Antoni Van Leeuwenhoek Hospital/the Netherlands Cancer Institute
-
Huitema A.
Slotervaart Hospital Department Of Pharmacy & Pharmacology
-
Huitema A.
Department Of Pharmacy And Pharmacology Slotervaart Hospital
-
BULT Auke
Department of Biomedical Analysis, Faculty of Pharmaceutical Sciences, Utrecht University
-
Bult Auke
Free University Amsterdam Department Of Analytical Chemistry And Applied Spectroscopy
-
BULT A.
Department of Pharmaceutical Analysis and Toxicology, Faculty of Pharmacy, University of Utrecht
-
Hillebrand M.
Department Of Pharmacy And Pharmacology Slotervaart Hospital/the Netherlands Cancer Institute
-
TEUNISSEN S.
Department of Pharmacy & Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute
-
SCHINKEL A.
Department of Molecular Biology, The Netherlands Cancer Institute
-
Schinkel A.
Department Of Molecular Biology The Netherlands Cancer Institute
-
Teunissen S.
Department Of Pharmacy & Pharmacology Slotervaart Hospital/the Netherlands Cancer Institute
-
ROSING H.
Department of Pharmacy and Pharmacology, Netherlands Cancer Institute/Slotervaart Hospital
-
TEN BOKKEL
Department of Medical Oncology, Antoni van Leeuwenhoek Hospital/Netherlands Cancer Institute
-
BEIJNEN J.
Department of Pharmacy and Pharmacology, Netherlands Cancer Institute/Slotervaart Hospital
-
Ten Bokkel
Department Of Medical Oncology Antoni Van Leeuwenhoek Hospital/the Netherlands Cancer Institute
-
Doyle E.
Department Of Drug Analysis Smithkline Beecham Pharmaceuticals
-
Mulder J.
Slotervaart Hospital Department Of Pharmacy & Pharmacology
-
Van Gorp
Slotervaart Hospital Department Of Pharmacy & Pharmacology
-
Koopman F.
Department Of Pharmacy And Pharmacology Netherlands Cancer Institute/slotervaart Hospital
-
LUSTIG V.
Department of Medical Oncology, Antoni van Leeuwenhoek Hospital/Netherlands Cancer Institute
-
ROSING H.
Dept. of Pharmacy and Pharmacology, Slotervaart Hospital, The Netherlands Cancer Institute
-
BEIJNEN J.
Dept. of Pharmacy and Pharmacology, Slotervaart Hospital, The Netherlands Cancer Institute
-
Van Der
Department Of Anatomy Vu University Medical Center
-
Jimeno J.
Pharma Mar S.a. Research And Development
-
Rosing H.
Dept. Of Pharmacy And Pharmacology Slotervaart Hospital The Netherlands Cancer Institute
-
Lustig V.
Department Of Medical Oncology Antoni Van Leeuwenhoek Hospital/netherlands Cancer Institute
-
Beijnen J.
Dept. Of Pharmacy And Pharmacology Slotervaart Hospital The Netherlands Cancer Institute
-
Beijnen J.
Slotervaart Hospital/netherlands Cancer Institute
-
Floriano P.
Pharmamar S.a. Research And Development
-
VAN DER
Slotervaartziek-enhuis
-
HILLEBRAND M.
Dept. of Pharmacy and Pharmacology, Slotervaart Hospital/Netherlands Cancer Institute
-
GOMEZ A.
Pharma Mar, S.A., Research and Development
-
FAIRCLOTH G.
Pharma Mar, S.A., Research and Development
-
CAMERON L.
Pharma Mar, S.A., Research and Development
-
HENRAR R.
EORTC-New Drug Development Office
-
VERMORKEN J.
Department of Medical Oncology, University Hospital Antwerpen
-
VAN ZOMEREN
Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute
-
DOYLE E.
Department of Drug Metabolism and Pharmacokinetics, SmithKline Beecham Pharmaceuticals
-
Van Zomeren
Department Of Pharmacy And Pharmacology Slotervaart Hospital/the Netherlands Cancer Institute
-
Mulder J.
Department Of Global Oral Health Radboud University Nijmegen Medical Centre College Of Dental Scienc
-
Meenhorst P.
Department Of Internal Medicine Slotervaart Hospital
-
Ter Heine
Department Of Pharmacy & Pharmacology Slotervaart Hospital/the Netherlands Cancer Institute
-
Heine R.
Slotervaart Hospital Department Of Pharmacy & Pharmacology
-
Ter Heine
Department Of Pharmacy And Pharmacology Slotervaart Hospital
-
Faircloth G.
Pharma Mar S.a. Research And Development
-
Vermorken J.
Department Of Medical Oncology University Hospital Antwerpen
-
DAVIES B.
Department of Drug Metabolism and Pharmacokinetics, SmithKline Beecham Pharmaceuticals
-
SCHINKEL A.
Division of Molecular Biology, The Netherlands Cancer Institute
-
VLAMING M.
Department of Molecular Biology, The Netherlands Cancer Institute
-
LANKHEET A.
Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute
-
LANGENBERG M.
Department of Medical Oncology, University Medical Center Utrecht
-
VOEST E.
Department of Medical Oncology, University Medical Center Utrecht
-
SCHELLENS J.
Beta Faculty, Department of Pharmaceutical Sciences, Division of Biomedical Analysis, Utrecht Univer
-
KOORNSTRA R.
Departments of Molecular Biology and Medical Oncology, Antoni van Leeuwenhoek Hospital/The Netherlan
-
LINN S.
Departments of Molecular Biology and Medical Oncology, Antoni van Leeuwenhoek Hospital/The Netherlan
-
KOKS C.
Department of Pharmacy, Slotervaart Hospital
-
DAVIDS M.
Slotervaart Hospital, Department of Pharmacy & Pharmacology
-
ROSING H.
Slotervaart Hospital, Department of Pharmacy & Pharmacology
-
VAN GORP
Slotervaart Hospital, Department of Pharmacy & Pharmacology
-
VAN GORP
Department of Internal Medicine, Slotervaart Hospital
-
CROMMENTUYN K.
Department of Pharmacy and Pharmacology, Slotervaart Hospital
-
Davids M.
Slotervaart Hospital Department Of Pharmacy & Pharmacology
-
Van Der
Slotervaart Hospital Department Of Pharmacy & Pharmacology
-
Van Der
Department Of Internal Medicine Slotervaart Hospital
-
Cameron L.
Pharma Mar S.a. Research And Development
-
Koks C.
Department Of Pharmacy Slotervaart Hospital
-
Linn S.
Departments Of Molecular Biology And Medical Oncology Antoni Van Leeuwenhoek Hospital/the Netherland
-
Voest E.
Department Of Medical Oncology University Medical Center Utrecht
-
Vlaming M.
Department Of Molecular Biology The Netherlands Cancer Institute
-
Lankheet A.
Department Of Pharmacy And Pharmacology Slotervaart Hospital/the Netherlands Cancer Institute
-
Koornstra R.
Departments Of Molecular Biology And Medical Oncology Antoni Van Leeuwenhoek Hospital/the Netherland
-
Langenberg M.
Department Of Medical Oncology University Medical Center Utrecht
-
Crommentuyn K.
Department Of Pharmacy And Pharmacology Slotervaart Hospital
-
Gomez A.
Pharma Mar S.a. Research And Development
-
Davies B.
Department Of Drug Metabolism And Pharmacokinetics Smithkline Beecham Pharmaceuticals
-
Van Der
Departement Wiskunde Katholieke Universiteit Leuven
著作論文
- Bio-analysis of docetaxel and hydroxylated metabolites in human plasma by high-performance liquid chromatography and automated solid-phase extraction
- Analysis of Ecteinascidin 743, a new potent marine-derived anticancer drug, in human plasma by high-performance liquid chromatography in combination with solid-phase extraction
- Quantification of topotecan and its metabolite N-desmethyltopotecan in human plasma, urine and faeces by high-performance liquid chromatographic methods
- Review on the analysis of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and its phase I and phase II metabolites in biological matrices, foodstuff and beverages
- High-performance liquid chromatographic determination of the novel antitumour drug topotecan and topotecan as the total of the lactone plus carboxylate forms, in human plasma
- Development and validation of a liquid chromatography-tandem mass spectrometry assay for the analysis of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and its metabolite 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine (N-OH-PhIP) in plasma
- A validated assay for the quantitative analysis of vatalanib in human EDTA plasma by liquid chromatography coupled with electrospray ionization tandem mass spectrometry
- Development and validation of a quantitative assay for the analysis of tamoxifen with its four main metabolites and the flavonoids daidzein, genistein and glycitein in human serum using liquid chromatography coupled with tandem mass spectrometry
- High-performance liquid chromatographic determination of the antifungal drug fluconazole in plasma and saliva of human immunodeficiency virus-infected patients
- Quantification of HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in peripheral blood mononuclear cell lysate using liquid chromatograph coupled with tandem mass spectrometry
- Quantification of protease inhibitors and non-nucleoside reverse transcriptase inhibitors in dried blood spots by liquid chromatography-triple quadrupole mass spectrometry
- Simultaneous quantification of the new HIV protease inhibitors atazanavir and tipranavir in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry